Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage. Version 4

Mutation Research - DNA Repair

Volumn 459, Issue 4, 2000, Pages 243-274

  Friedberg, Errol C ^a   Meira, Lisiane B ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DATA BASE; DNA DAMAGE; GENE MUTATION; INFORMATION; LITERATURE; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0034738030     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(00)00006-9     Document Type: Article

References (108)

1. Friedberg E.C., Meira L.B., Cheo D.L. Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage. Version 2. Mutat. Res. 407:1998;217-226.
2. Gu H., Marth J.D., Orban P.C., Mossmann H., Rajewsky K. Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science. 265:1994;103-106.
3. Xanthoudakis S., Smeyne R.J., Wallace J.D., Curran T. The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. Proc. Natl. Acad. Sci. USA. 93:1996;8919-8923.
4. L.B. Meira, E.C. Friedberg, unpublished observations.
5. Ludwig D.L., MacInnes M.A., Takiguchi Y., Purtymun P.E., Henrie M., Flannery M., Meneses J., Pedersen R.A., Chen D.J. A murine AP-endonuclease gene-targeted deficiency with post-implantation embryonic progression and ionizing radiation sensitivity. Mutat. Res. 409:1998;17-29.
6. Bentley D., Selfridge J., Millar J.K., Samuel K., Hole N., Ansell J.D., Melton D.W. DNA ligase I is required for fetal liver erythropoiesis but is not essential for mammalian cell viability. Nat. Genet. 13:1996;489-491.
7. Klunglund A., Rosewell I., Hollenbach S., Larsen E., Daly G., Epe B., Seeberg E., Lindahl T., Barnes D.E. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc. Natl. Acad. Sci. USA. 96:1999;13300-13305.
8. H. Nilsen, I. Rosewell, P. Robins, G. Slupphaug, H.E. Krokan, T. Lindahl, D.E. Barnes, submitted for publication.
9. Engelward B.P., Weeda G., Wyatt M.D., Broekhof J.L., de Wit J., Donker I., Allan J.M., Gold B., Hoeijmakers J.H.J., Samson L.D. Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc. Natl. Acad. Sci. USA. 94:1997;13087-13092.
10. 4-ethenocytosine or 8-oxoguanine. Proc. Natl. Acad. Sci. USA. 94:1997;12869-12874.
11. Elder R.H., Jansen J.G., Weeks R.J., Willington M.A., Deans B., Watson A.J., Mynett K.J., Bailey J.A., Cooper D.P., Rafferty J.A., Heeran M.C., Wijnhoven S.W., Van Zeeland A.A., Margison G.P. Alkylpurine-DNA-N-glycosylase knockout mice show increased susceptibility to induction by mutations by methyl methanesulfonate. Mol. Cell. Biol. 18:1998;5828-5837.
12. H. Yang, J.H. Miller, unpublished observations.
13. McWhir J., Selfridge J., Harrison D.J., Squires S., Melton D.W. Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Nat. Genet. 5:1993;217-224.
14. Weeda G., Donker I., de Wit J., Morreau H., Janssens R., Vissers C.J., Nigg A., Van Steeg H., Bootsma D., Hoeijmakers J.H.J. Disruption of the mouse ERCC1 gene results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence. Curr. Biol. 7:1997;427-439.
15. de Vries A., Van Oostrom C.T.M., Hofhuis F.M.A., Dortant P.M., Berg R.J.W., de Gruijl F.R., Wester P.W., Van Kreijl C.F., Capel P.J.A., Van Steeg H., Verbeek S.J. Increased susceptibility to ultraviolet-B and carcinogenesis in mice lacking the DNA repair gene XPA. Nature. 377:1995;169-173.
16. Nakane H., Takeuchi S., Yuba S., Saijo M., Nakatsu Y., Murai H., Nakatsuru Y., Ishikawa T., Hirota S., Kitamura Y., Kato Y., Tsunoda Y., Miyauchi H., Horio T., Tokunaga T., Matsunaga T., Nikaido O., Nishimune Y., Okada Y., Tanaka K. High incidence of ultraviolet-B or chemical carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature. 377:1995;165-168.
17. de Vries A., Berg R.J.W., Wijnhoven S., Westerman A., Wester P.W., Van Kreijl C.F., Capel P.J.A., de Gruijl F.R., Van Kranen H.J., Van Steeg H. XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of UVB. Oncogene. 16:1998;2205-2212.
18. Sands A.T., Abuin A., Sanchez A., Conti C.J., Bradley A. High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature. 377:1995;162-165.
19. Cheo D.L., Ruven H.J.T., Meira L.B., Hammer R.E., Burns D.K., Tappe N.J., Van Zeeland A.A., Mullenders L.H.F., Friedberg E.C. Characterization of defective nucleotide excision repair in XPC mutant mice generated by targeted gene replacement. Mutat. Res. 374:1997;1-9.
20. G.T.J. Van der Horst, H. Van Steeg, K. Tanaka, A. Bradley, J.H.J. Hoeijmakers, et al., in preparation.
21. Cheo D.L., Meira L.B., Hammer R.E., Burns D.K., Doughty A.T.B., Friedberg E.C. Synergistic interactions between XPC and p53 mutations in double mutant mice: neural tube abnormalities and accelerated UV radiation-induced skin cancer. Curr. Biol. 6:1996;1691-1694.
22. Meira L.B., Cheo D.L., Reis A., Hammer R.E., Burns D.K., Friedberg E.C. Genetic interaction between HAP1(REF-1) and p53. Nat. Genet. 17:1997;145.
23. Cheo D.L., Meira L.B., Burns D.K., Reis A.M., Issac T., Friedberg E.C. UVB radiation-induced skin cancer in mice defective in the Xpc, Trp53, and Apex (HAP1) genes: genotype-specific effects on cancer predisposition and pathology of tumors. Cancer Res. 60:2000;1580-1584.
24. D.L. Cheo, A.M. Reis, N. Claij, L.B. Meira, D.K. Burns, H. te Riel, E.C. Friedberg, unpublished observations.
25. G. Weeda, I. Donker, J.L.M. Broekhof, J. de Wit, J.H.J. Hoeijmakers, Lethal and Viable Targeted Mutations in the Basal Transcription/DNA Repair Helicase XPB: A Mouse Model for the Human Repair Disorder Xeroderma Pigmentosum, in preparation.
26. de Boer J., Donker I., de Wit J., Hoeijmakers J.H.J., Weeda G. Disruption of the mouse xeroderma pigmentosum group D DNA repair/basal transcription gene results in preimplantation lethality. Cancer Res. 58:1998;89-94.
27. de Boer J., de Wit J., Van Steeg H., Berg R.J.W., Morreau H., Visser P., Lehmann A.R., Duran M., Hoeijmakers J.H.J., Weeda G. A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. Mol. Cell. 1:1998;981-990.
28. Harada Y.-N., Shiomi N., Koike M., Ikawa M., Okabe M., Hirota S., Kitamura Y., Kitagawa M., Matsunaga T., Nakaido O., Shiomi T. Post-natal growth failure, a short life span, and early onset of cellular senescence and subsequent immortalization in mice lacking the xeroderma pigmentosum group G gene. Mol. Cell. Biol. 19:1999;2366-2372.
29. T. Shiomi, personal communication.
30. J. Ng, K. Sugasawa, G.T.J. Van der Horst, J.H.J. Hoeijmakers, et al., in preparation.
31. J. Ng, K. Sugasawa, H. Vrieling, J.H.J. Hoeijmakers, G.T.J. Van der Horst, et al., manuscript in preparation.
32. G.T.J. Van der Horst, L.B. Meira, K. Henning, E.C. Friedberg, J.H.J. Hoeijmakers, et al., in preparation.
33. Van der Horst G.T.J., Van Steeg H., Berg R.J.W., Van Gool A.J., de Wit J., Weeda G., Morreau H., Beems R.B., Van Kreijl C.F., de Gruijl F.R., Bootsma D., Hoeijmakers J.H.J. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell. 89:1997;425-435.
34. J.H.J. Hoeijmakers, et al., in preparation.
35. Prolla T.A., Baker S.M., Harris A.C., Tsao J.-L., Yao X., Bronner C.E., Zheng B., Gordon M., Reneker J., Arnheim N., Shibata D., Bradley A., Liskay R.M. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat. Genet. 18:1998;276-279.
36. Baker S.M., Bronner C.E., Zhang L., Plug A.W., Robatzek M., Warren G., Elliott E.A., Yu J., Ashley T., Arnheim N., Flavell R.A., Liskay R.M. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell. 82:1995;309-319.
37. -/-; Min mice. Cancer Res. 58:1998;1087-1089.
38. de Wind N., Dekker M., Berns A., Radman M., te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell. 82:1995;321-330.
39. Reitmair A.H., Schmits R., Ewel A., Bapat B., Redston M., Mitri A., Waterhouse P., Mittrucker H.W., Wakeham A., Liu B., Thomason A., Griesser H., Gallinger S., Ballhausen W.G., Fishel R., Mak T.W. MSH2 deficient mice are viable and susceptible to lymphoid tumors. Nat. Genet. 11:1995;64-70.
40. Reitmair A.H., Cai J.C., Bjerknes M., Redston M., Cheng H., Pind M.T.L., Hay K., Mitri A., Bapat B.V., Mak T.W., Gallinger S. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res. 56:1996;2922-2926.
41. de Wind N., Dekker M., Van Rossum A., Van der Valk M., te Riele H. Mouse models for hereditary nonpolyposis colorectal cancer. Cancer Res. 58:1998;248-255.
42. Cranston A., Bocker T., Reitmair A., Palazzo J., Wilson T., Mak T., Fishel R. Female embryonic lethality in mice nullizygous for both Msh2 and p53. Nat. Genet. 17:1997;114-118.
43. Toft N.J., Arends M.J., Wyllie A.H., Clarke A.R. No female embryonic lethality in mice nullizygous for Msh2 and p53. Nat. Genet. 18:1998;17.
44. D.L. Cheo, L.B. Meira, H. te Riele, E.C. Friedberg, unpublished observations.
45. Edelmann W., Cohen P.E., Kneitz B., Winand N., Lia M., Heyer J., Kolodner R., Pollard J.W., Kucherlapati R. Mammalian MutS homologue 5 is required for chromosome pairing in meiosis. Nat. Genet. 21:1999;123-127.
46. de Vries S.S., Baart E.B., Dekker M., Siezen A., de Rooij D.G., de Boer P., te Riel H. Mouse MutS-like protein Msh5 is required for proper chromosome synapsis in male and female meiosis. Genes Dev. 13:1999;523-531.
47. Edelmann W., Yang K., Umar A., Heyer J., Lau K., Fan K., Liedtke W., Cohen P.E., Kane M.F., Lipford J.R., Yu N., Crouse G.F., Pollard J.W., Kunkel T., Lipkin M., Kolodner R., Kucherlapati R. Mutation in the mismatch repair gene Msh6 causes cancer susceptibility. Cell. 91:1997;467-477.
48. Baker S.M., Plug A.W., Prolla T.A., Bronner C.E., Harris A.C., Yao X., Christie D.-M., Monell C., Arnheim N., Bradley A., Ashley T., Liskay R.M. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat. Genet. 13:1996;336-342.
49. Edelmann W., Cohen P.E., Kane M., Lau K., Morrow B., Bennett S., Umar A., Kunkel T., Cattoretti G., Chaganti R., Pollard J.W., Kolodner R.D., Kucherlapati R. Meiotic pachytene arrest in MLH1-deficient mice. Cell. 85:1996;1125-1134.
50. Yao X., Buermeyer A.B., Narayanan L., Tran D., Baker S.M., Prolla T.A., Glazer P.M., Liskay R.M., Arnheim N. Different mutator phenotypes in Mlh1-versus Pms2-deficient mice. Proc. Natl. Acad. Sci. USA. 96:1999;6850-6855.
51. Edelmann W., Yang K., Kuraguchi M., Heyer J., Lia M., Kneitz B., Fan K., Brown A.M.C., Lipkin M., Kucherlapati R. Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice. Cancer Res. 59:1999;1301-1307.
52. Tsuzuki T., Sakumi K., Shiraishi A., Kawate H., Igarashi H., Iwakuma T., Tominaga Y., Zhang S., Shimizu S., Ishikawa T., Nakamura K., Nakao K., Katsuki M., Sekiguchi M. Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent. Carcinogenesis. 17:1996;1215-1220.
53. B. Glassner, B.P. Engelward, L. Samson, J.H.J. Hoeijmakers, G. Weeda, unpublished observations.
54. Kawate H., Sakumi K., Tsuzuki T., Nakatsuru Y., Ishikawa T., Takahashi S., Takano H., Noda T., Sekiguchi M. Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes. Proc. Natl. Acad. Sci. USA. 95:1998;5116-5120.
55. Tebbs R.S., Flannery M.L., Meneses J.J., Hartmann A., Tucker J.D., Thompson L.H., Cleaver J.E., Pederson R.A. Requirement for the Xrcc1 DNA base excision repair gene during early mouse development. Dev. Biol. 208:1999;513-529.
56. Gao Y., Sun Y., Frank K.M., Dikkes P., Fujiwara Y., Seidl K.J., Sekiguchi J.M., Rathbun G.A., Swat W., Wang S., Bronson R.T., Malynn B.A., Bryans M., Zhu C., Chaudhuri J., Davidson L., Ferrini R., Stamato T., Orkin S.H., Greenberg M.E., Alt F.W. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell. 95:1998;891-902.
57. Zhu C., Bogue M.A., Lim D.-S., Hasty P., Roth D.B. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell. 86:1996;379-389.
58. Nussenzweig A., Chen C., de Costa Soares V., Sanchez M., Sokol K., Nussenzweig M.C., Li G.C. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature. 382:1996;551-555.
59. Ouyang H., Nussenzweig A., Kurimasa A., de Costa Soares V., Li X., Cordon-Cardo C., Li W.H., Cheong N., Nussenzweig M., Iliakis G., Chen D.J., Li G.C. Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination in vivo. J. Exp. Med. 186:1997;921-929.
60. Gu Y., Seidl K.J., Rathbun G.A., Zhu C., Manis J.P., Van der Stoep N., Davidson L., Cheng H.-L., Sekiguchi J.M., Frank K., Stanhope-Baker P., Schlissel M.S., Roth D.B., Alt F.W. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity. 7:1997;653-665.
61. Frank K.M., Sekiguchi J.M., Seidl K.J., Swat W., Rathbun G.A., Cheng H.L., Davidson L., Kangaloo L., Alt F.W. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature. 396:1998;173-177.
62. Barnes D.E., Stamp G., Rosewell I., Denzel A., Lindahl T. Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Curr. Biol. 8:1998;1395-1398.
63. Gao Y., Chuadhuri J., Zhu C., Davidson L., Weaver D.T., Alt F.W. A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for Ku in V(D)J recombination. Immunity. 9:1998;367-376.
64. Taccioli G.E., Amatucci A.G., Beamish H.J., Gell D., Xiang X.H., Torres Arzayus M.I., Priestley A., Jackson S.P., Marshak Rothstein A., Jeggo P.A., Herrera V.L.M. Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity. 9:1998;355-356.
65. Kurimasa A., Ouyang H., Dong L.-J., Wang S., Li X., Cordon-Cardo C., Chen D.J., Li G.C. Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis. Proc. Natl. Acad. Sci. USA. 96:1999;1403-1408.
66. Wang Z.-Q., Auer B., Stingl L., Berghammer H., Haidacher D., Schweiger M., Wagner E.F. Mice lacking ADPRT and poly(ADP)-ribosylation develop normally but are susceptible to skin disease. Genes Dev. 9:1995;509-520.
67. de Murcia J.M., Niedergang C., Trucco C., Ricoul M., Dutrillaux B., Mark M., Oliver F.J., Masson M., Dierich A., LeMeur M., Walztinger C., Chambon P., de Murcia G. Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc. Natl. Acad. Sci. USA. 94:1997;7303-7307.
68. Matsutani M., Suzuki H., Kamada N., Watanabe M., Ueda O., Nozaki T., Jishage K.I., Watanabe T., Sugimoto T., Nakagama H., Ochiya T., Sugimura T. Poly (ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA. 96:1999;2301-2304.
69. Morrison C., Smith G.C.M., Stingl L., Jackson S.P., Wagner E.F., Wang Z.Q. Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis. Nat. Genet. 17:1997;479-482.
70. Luo G., Yao M.S., Bender C.F., Mills M., Bladl A.R., Bradley A., Petrini J.H. Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc. Natl. Acad. Sci. USA. 96:1999;7376-7381.
71. Tsuzuki T., Fujii Y., Sakumi K., Tominaga Y., Nakao K., Sekiguchi M., Matsushiro A., Yoshimura Y., Morita T. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. USA. 93:1996;6236-6240.
72. -/- background. Mol. Cell. Biol. 19:1999;8686-8693.
73. D. Pittman, J. Schimenti, Mid-gestation lethality in mice deficient for the RecA homolog, Rad51d/Rad51L3, Genesis, in press.
74. Lim D.-S., Hasty P. A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol. 16:1996;7133-7143.
75. Rijkers T., Van den Ouweland J., Morolli B., Rolink A.G., Baarends W.M., Van Sloun P.P.H., Lohman P.H.M., Pastink A. Targeted inactivation of mouse RAD52 reduces homologous recombination but not resistance to ionizing radiation. Mol. Cell. Biol. 18:1998;6423-6429.
76. Essers J., Hendriks R.W., Swagemakers S.M.A., Troelstra C., de Wit J., Bootsma D., Hoeijmakers J.H.J., Kanaar R. Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination. Cell. 89:1997;195-204.
77. Xu X., Wagner K.-U., Larson D., Weaver Z., Li C., Ried T., Henninghausen L., Wynshaw-Boris A., Deng C.-X. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat. Genet. 22:1999;37-43.
78. Gowen L.C., Johnson B.L., Latour A.M., Sulik K.K., Koller B.H. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet. 12:1996;191-194.
79. Shen S.-X., Weaver Z., Xu X., Li C., Weinstein M., Chen L., Guan X.-Y., Ried T., Deng C.-X. A targeted disruption of the murine Brca1 gene causes γ-irradiation hypersensitivity and genetic instability. Oncogene. 17:1998;3115-3124.
80. Liu C.-Y., Flesken-Nikitin A., Li S., Zeng Y., Lee W.-H. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 10:1996;1835-1843.
81. Sharan S.K., Morimatsu M., Albrecht U., Lim D.-S., Regel E., Dinh C., Sands A., Eichele G., Hasty P., Bradley A. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature. 386:1997;804-810.
82. Ludwig T., Chapman D.L., Papaioannou V.E., Efstratiadis A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11:1997;1226-1241.
83. Patel K.J., Yu V.P., Lee H., Corcoran A., Thistlthwaite F.C., Evans M.J., Colledge W.H., Friedman L.S., Ponder B.A., Venkitaraman A.R. Involvement of Brca2 in DNA repair. Mol. Cell. 1:1998;347-357.
84. Suzuki A., de la Pompa J.L., Hakem R., Elia A., Yoshida R., Mo R., Niushina H., Chuang T., Wakeham A., Itie A., Koo W., Billia P., Fukumoto M., Wai C.C., Mak T.W. Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 11:1997;1242-1252.
85. Connor F., Bertwistle D., Mee P.J., Ross G.M., Swift S., Grigorieva E., Tybulewicz V.L.J., Ashworth A. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat. Genet. 17:1997;423-430.
86. Cressman V.L., Backlund D.C., Avrutskaya A.V., Leadon S.A., Godfrey V., Koller V.H. Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice. Mol. Cell. Biol. 19:1999;7061-7075.
87. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature. 356:1992;215-221.
88. Tsukada T., Tomooka Y., Takai S., Ueda Y., Nishikawa S.I., Yagi T., Tokunaga T., Takeda N., Suda Y., Abe S., Matsuo I., Ikawa Y., Aizawa S. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene. 8:1993;3313-3322.
89. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4:1994;1-7.
90. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82:1995;675-684.
91. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 86:1996;159-171.
92. Xu Y., Baltimore D. Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Dev. 10:1996;2401-2410.
93. Xu Y., Ashley T., Brainerd E.E., Bronson R.T., Meyn M.S., Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10:1996;2411-2422.
94. Barlow C., Liyanage M., Moens P.B., Deng C.-X., Ried T., Wynshaw-Boris A. Partial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles. Nat. Genet. 17:1997;462-466.
95. Barlow C., Brown K.D., Deng C.-X., Tagle D.A., Wynshaw-Boris A. Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. Nat. Genet. 17:1997;453-456.
96. Wang Y.A., Elson A., Leder P. Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. Proc. Natl. Acad. Sci. USA. 94:1997;14590-14595.
97. -/- mice. Mol. Cell. Biol. 18:1998;4385-4390.
98. Liao M.-J., Van Dyke T. Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma. Genes Dev. 13:1999;1246-1250.
99. Serrano M., Lee H., Chin L., Cordon-Cardo C., Beach D., DePinho R.A. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 85:1996;27-37.
100. Zindy F., Van Deursen J., Grosveld G., Sherr C.J., Roussel M.F. INK4d-deficient mice are fertile despite testicular atrophy. Mol. Cell. Biol. 20:2000;372-378.
101. Hollander M.C., Sheikh M.S., Bulavin D.V., Lundgren K., Augeri-Henmueller L., Shehee R., Molinaro T.A., Kim K.E., Tolosa E., Ashwell J.D., Rosenberg M.P., Zhan Q., Fernandez-Salguero P.M., Morgan W.F., Deng C.-X., Fornace A.J. Jr. Genomic instability in Gadd45a-deficient mice. Nat. Genet. 23:1999;176-184.
102. H.P. Roest, J.H.J. Hoeijmakers, et al., unpublished observations.
103. Roest H.P., Van Klaveren J., de Wit J., Van Gurp C.G., Koken M.H.M., Vermey M., Van Roijen J.H., Hoogerbrugge J.W., Vreeburg J.T.M., Baarends W.M., Bootsma D., Grootegoed J.A., Hoeijmakers J.H.J. Inactivation of the HR6B ubiquitin-conjugating DNA repair enzyme in mice causes male sterility associated with chromatin modification. Cell. 86:1996;799-810.
104. Lebel M., Leder P. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proc. Natl. Acad. Sci. USA. 95:1998;13097-13102.
105. Chester N., Kuo F., Kozak C., O'Hara C.D., Leder P. Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene. Genes Dev. 12:1998;3382-3393.
106. R.A. Schultz, personal communication.
107. Chen M., Tomkins D.J., Auerbach W., McKerlie C., Youssoufian H., Liu L., Gan O., Carreau M., Auerbach A., Groves T., Guidos C.J., Freedman M.H., Cross J., Percy D.H., Dick J.E., Joyner A.L., Buchwald M. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anemia. Nat. Genet. 12:1996;448-451.
108. Whitney M.A., Royle G., Low M.J., Kelly M.A., Axthelm M.K., Reifsteck C., Olson S., Braun R.E., Heinrich M.C., Rathbun R.K., Bagby G.C., Grompe M. Germ cell defects and hemopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood. 88:1996;49-58.